GC Cell (XKRX:144510) Total Liabilities : ₩115,983 Mil (As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is GC Cell Total Liabilities?

GC Cell's Total Liabilities for the quarter that ended in Dec. 2024 was ₩115,983 Mil.

GC Cell's quarterly Total Liabilities increased from Jun. 2024 (₩131,771.87 Mil) to Sep. 2024 (₩132,066.12 Mil) but then declined from Sep. 2024 (₩132,066.12 Mil) to Dec. 2024 (₩115,983.43 Mil).

GC Cell's annual Total Liabilities declined from Dec. 2022 (₩130,783.67 Mil) to Dec. 2023 (₩123,691.62 Mil) and declined from Dec. 2023 (₩123,691.62 Mil) to Dec. 2024 (₩115,983.43 Mil).

GC Cell Total Liabilities Historical Data

The historical data trend for GC Cell's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GC Cell Total Liabilities Chart

GC Cell Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

24,537.39

129,890.84

130,783.67

123,691.62

115,983.43

GC Cell Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															123,691.62	131,153.09	131,771.87	132,066.12	115,983.43

GC Cell Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

GC Cell's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	81582.107	+	(26598.568	+	5733.043
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	2069.71	+	0)
	=	115,983

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	578349.164	-	462365.736
	=	115,983

GC Cell's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	81582.107	+	(26598.568	+	5733.043
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	2069.71	+	0)
	=	115,983

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	578349.164	-	462365.736
	=	115,983

GC Cell Total Liabilities Related Terms

Thank you for viewing the detailed overview of GC Cell's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

GC Cell Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » GC Cell Corp (XKRX:144510) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

30 beongil to giheung-gu, Gyeonggi, 107 Lee Hyun, Yongin, KOR, 16 924

Website

https://www.gccell.com

GC Cell Corp engages in the provision of anti-cancer immunotherapy. The company is developing an anticancer drug, which is in Phase II clinical trials; and stem cell treatment drugs. It also provides cell banking, sample inspection, clinical trial, and bio logistics services.

GC Cell Headlines

No Headlines